Modified titration of donanemab reduces ARIA risk and maintains amyloid reduction. - Wang H; Serap Monkul Nery E; Ardayfio P; Khanna R; Otero Svaldi D; Gueorguieva I; Shcherbinin S; Andersen SW; Hauck PM; Engle SE; Brooks DA; Collins EC; et al. (Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025)